Antibiotics and the Nervous System—Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?
Open accessThe DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Antibiotics as antibacterial drugs have saved many lives, but have also become a victim of their own success. Their widespread abuse reduces their anti-infective effectiveness and causes the development of bacterial resistance. Moreover, irrational antibiotic therapy contributes to gastrointestinal dysbiosis, that increases the risk of the development of many diseases, including neurological and psychiatric. One of the potential options for restoring homeostasis is the use of oral antibiotics that are poorly absorbed from the gastrointestinal tract (e.g., rifaximin alfa). Thus, antibiotic therapy may exert neurological or psychiatric adverse drug reactions which are often considered to be overlooked and undervalued issues. Drug-induced neurotoxicity is mostly observed after beta-lactams and quinolones. Penicillin may produce a wide range of neurological dysfunctions, including encephalopathy, behavioral changes, myoclonus or seizures. Their pathomechanism results from the disturbances of gamma-aminobutyric acid-GABA transmission (due to the molecular similarities between the structure of the β-lactam ring and GABA molecule) and impairment of the functioning of benzodiazepine receptors (BZD). However, on the other hand, antibiotics have also been studied for their neuroprotective properties in the treatment of neurodegenerative and neuroinflammatory processes (e.g., Alzheimer’s or Parkinson’s diseases). Antibiotics may, therefore, become promising elements of multi-targeted therapy for these entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Generally, although promising, two main concerns remain about the use of antibiotics in PD treatment: (i) antibiotics can kill some specific microbial populations leading to intestinal dysbiosis and neurological dysfunction and (ii) their prolonged and widespread intake would favor antibiotic resistance [213,300,301].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
The cited source says what the claim attributes to it.
In the citing paper
“Generally, although promising, two main concerns remain about the use of antibiotics in PD treatment: (i) antibiotics can kill some specific microbial populations leading to intestinal dysbiosis and neurological dysfunction and (ii) their prolonged and widespread intake would favor antibiotic resistance [213,300,301].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
In the citing paper
“certain antibiotics can inhibit the activity of matrix metalloproteinases and prevent mitochondria dysfunction, microglia activation, protein misfolding and α-synuclein aggregation [211,212,213,214,215]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
In the citing paper
“Moreover, quinolones and β-lactams are known to trigger neurotoxicity through their interference with gamma-aminobutyric acid and benzodiazepine receptors signaling [213].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed Central · Cited by 8,022
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052 · cited 1×
“Spontaneous mutations are also an important cause, allowing the acquisition of bacterial resistance to antibiotics without the exchange of genetic material between various strains [5].”
BackgroundAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370 · cited 1×
“The discovery of antibiotic agents and their introduction into clinical practice is considered to be one of the greatest medical breakthrough of the 20th century [1].”
BackgroundGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 1×
“It was also found that higher concentrations of Enterobacteriaceae were directly proportional to gait and postural instability [34,43].”
BackgroundA brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628 · cited 3×
“in Medicine or Physiology in 1945 for the discovery of penicillin and its curative effect in various infectious diseases) [2,3].”
BackgroundHuman gut microbiome: Hopes, threats and promises
Cani, P. D. (2018) · Gut · doi:10.1136/gutjnl-2018-316723 · Cited by 1,386
Research works printed but not linked: 7
- Zagaria M.A.E. Antibiotic therapy: Adverse effects and dosing considerations US Pharm 2013 38 18 20
- Demler T.L. Drug-induced neurologic conditions US Pharm 2014 39 47 51
- Jain K.K. Chapter 1: Epidemiology and Clinical Significance Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 1 5
- Jain K.K. Chapter 2: Pathomechanisms of Drug-Induced Neurological Disorders Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 7 12
- File T.M. Tan J.S. Recommendations for using imipenem-cilastatindthe most broad spectrum antibiotic Hosp. Formul. 1987 22 534 542
- Liu X. Microbiome Yale J. Biol. Med. 2016 89 275 276
- Kathait J. Rawat A.S. Beta-lactam antibiotics induced neurotoxicity IOSR J. Pharm. 2020 10 1 7
Cited by
Haddad, N., Carr, M., Balian, S., Lannin, J., Kim, Y., Toth, C., & Jarvis, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121843 · Cited by 96
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Hemdan, M., Abuelhaded, K., Shaker, A. A. S., Ashour, M. M., Abdelaziz, M. M., Dahab, M. I., Nassar, Y. A., Sarguos, A. M. M., Zakaria, P. S., Fahmy, H. A., et al. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100783 · Cited by 56
An overview of ATP synthase, inhibitors, and their toxicity
Althaher, A. R., & Alwahsh, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22459 · Cited by 45
The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration
Borbolis, F., Mytilinaiou, E., & Palikaras, K. (2023) · Cells · doi:10.3390/cells12030429 · Cited by 46
Brar, B., Marwaha, S., Poonia, A. K., Koul, B., Kajla, S., & Rajput, V. D. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03404-3 · Cited by 48
Lab-based meat the future food
Li, C. X., Zainal, N. A. A. B., Luang‐In, V., & Ling, N. (2022) · Environmental Advances · doi:10.1016/j.envadv.2022.100315 · Cited by 40
Srivastava, P., & Kim, K.-S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112370 · Cited by 36
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence
Butranova, O. I., Ushkalova, E. A., Zyryanov, S. K., Станиславович, Ч. М., & Александровна, Б. Е. (2023) · Biomedicines · doi:10.3390/biomedicines11061633 · Cited by 37
Mancinetti, F., Marinelli, A., Boccardi, V., & Mecocci, P. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111998 · Cited by 33
Bidirectional Interaction between Tetracyclines and Gut Microbiome
JAROSZEWSKI, J. J., Mamun, N., & Czaja, K. (2023) · Antibiotics · doi:10.3390/antibiotics12091438 · Cited by 26
“Alterations in the composition of gut microbiota can be induced by several exogenous factors, with antibiotic abuse being the most powerful [53,54].”
Omar, N. N., Mosbah, R., Sarawi, W. S., Medhet, M., & Badr, A. M. (2022) · Molecules · doi:10.3390/molecules27134069 · Cited by 21
“RFX was shown as a prominent factor in shaping the gut microbiome community structure [22], suggesting that RFX has autophagy modulation action.”
BackgroundAlthubyani, A. A., Canto, S., Pham, H., Holger, D. J., & Rey, J. A. (2024) · Drugs in Context · doi:10.7573/dic.2024-3-3 · Cited by 22
“101 The lipophilicity, in addition to other factors such as low protein binding and relatively small molecular size, may explain the excellent BBB permeability of FQs. 101 Intrigu-ingly, the ability of FQs to penetrate the CNS does not consistently align with their likelihood of causing seizures, meaning that FQ-induc…”
BackgroundInfluentialBilal, M., Zöller, M., Fuhr, U., Jaehde, U., Ullah, S., Liebchen, U., Büsker, S., Zander, J., Flury, B. B., & Taubert, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00309-23 · Cited by 17
“function should also be carefully monitored when cefepime is combined with potentially nephrotoxic antibiotics (such as aminoglycosides) or potent diuretics (43).”
BackgroundWei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
The Effect of Antibiotics on the Nervous System: Importance for Anesthesiology and Intensive Care
Radkowski, P., Oszytko, J., Sobolewski, K., Trachte, F., Onichimowski, D., & Majewska, M. (2025) · Antibiotics · doi:10.3390/antibiotics14060622 · Cited by 14
Neurodegeneration, Mitochondria, and Antibiotics
Suarez-Rivero, J. M., López‐Pérez, J., Muela‐Zarzuela, I., Pastor‐Maldonado, C. J., Cilleros-Holgado, P., Gómez-Fernández, D., Álvarez-Córdoba, M., Munuera-Cabeza, M., Talaverón-Rey, M., Povea-Cabello, S., et al. (2023) · Metabolites · doi:10.3390/metabo13030416 · Cited by 10
The tale of antibiotics beyond antimicrobials: Expanding horizons
Yadav, S., Shah, D., Dalai, P., & Agrawal-Rajput, R. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156285 · Cited by 12
Kukreja, B., Jeon, S. T., Cao, W., Rusu, B., Harrison, C. F., Ghazisaeidi, S., Tahmasian, N., Feng, M. Y., Chan, R., Loan, A., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-025-02162-3 · Cited by 8
Soto-Garcia, L. F., Guerrero-Rodriguez, I. D., Hoang, L., Laboy-Segarra, S. L., Phan, N., Villafuerte, E., Lee, J., & Nguyen, K. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713272 · Cited by 7
Enteric nervous system in microbiota-associated gut inflammation
Yang, C., Lan, X., Zhong, H., Geng, J., & Wang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735727 · Cited by 7
“Beyond dietary factors, pharmacological interventions constitute another critical driver of microbial dysregulation, with antibiotic misuse representing the most signi fi cant contributor (78, 79).”
Antibiotic-induced neurological adverse drug reactions
Lacroix, C., Pietri, T., Montero, V., Soeiro, T., Rouby, F., Blin, O., Guilhaumou, R., & Micallef, J. (2023) · Therapies · doi:10.1016/j.therap.2023.09.008 · Cited by 6
Darbandi, N., Komijani, M., & Tajiani, Z. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24942 · Cited by 6
Chi, F., Chen, K., Yin, Y., Hakovirta, J. R., & Saris, P. E. J. (2026) · Sustainable Microbiology · doi:10.1093/sumbio/qvag002 · Cited by 7
“…given the neuroactive and neurotoxic properties exhibited by many antibiotic classes (Rothstein 2005 , Champagne-Jorgensen 2019 , Negatu 2020 , Hurkacz 2021 et al. 2021 ), highlighting their potential to mitigate PD-related pathologies such as α -syn misfolding, mitochondrial dysfunction…”
Nádaská, D., & Malík, I. (2025) · Applied Sciences · doi:10.3390/app15158350 · Cited by 4
TAN, J., Zhou, P. Y., Chua, N. G. S., Hung, K. C., Lee, H. L. W., Lee, L. W., Lim, J. L., Lim, Y. C. S., Liew, Y., Loo, L. W., et al. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.05.007 · Cited by 4
Botanical compounds:Apromising control strategy against Trypanosoma cruzi
Abbas, R. Z., Qureshi, M. A., & Saeed, Z. (2025) · Boletin Latinoamericano y del Caribe de plantas Medicinales y Aromaticas · doi:10.37360/blacpma.25.24.3.23 · Cited by 4
“Antibiotics also have several other problems, i.e., drug residues, public health concerns, environmental contamination, etc. (Hurkacz et al ., 2021).”
Biomarkers of Antibiotic Toxicity: A Focus on Metronidazole
Bariweni, M. W., Patel, V. B., Zariwala, G. M., & Ozolua, R. I. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07392-2_75 · Cited by 3
Domínguez-González, D., Romero-Llopis, B., Roldán-Lázaro, M., Baquero, L., Noverques, R., Pallardó, F. V., Navarro, J. A., & González‐Cabo, P. (2024) · Redox Experimental Medicine · doi:10.1530/rem-24-0004 · Cited by 5
Cattaneo, D., Bavaro, D. F., & Bartoletti, M. (2025) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001343 · Cited by 2
Prakasam, S., Paramasivam, S., Senthilkumar, S., Giribabu, K., & Suresh, C. (2026) · Dalton Transactions · doi:10.1039/d5dt02477c · Cited by 2
Anaya, J., & Sánchez, R. M. (2023) · Progress in heterocyclic chemistry · doi:10.1016/b978-0-443-18939-5.00018-4 · Cited by 2
Neuropsychopharmacological Aspects of Antibiotic Action
Sergeev, Y. A., & Beyer, E. (2025) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-1-2-113-123 · Cited by 2
Antioxidant Defense: Key Mechanism of Lead Intolerance
Verma, M. K., Paul, A., & Roy, M. (2024) · Environmental contamination remediation and management · doi:10.1007/978-3-031-46146-0_12 · Cited by 2
Eslami, H., Rokhzadi, K., Basiri, M., Esmaeili‐Mahani, S., Mahmoodi, Z., & Haji-Allahverdipoor, K. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01279-9 · Cited by 3
“A clinically established and safe drug, minocycline, is currently being reconsidered as a candidate agent for some neurodegenerative diseases [20, 21].”
Biomarkers of Antibiotic Toxicity: A Focus on Metronidazole
Bariweni, M. W., Patel, V. B., Zariwala, G. M., & Ozolua, R. I. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87225-0_75-1 · Cited by 1
Можокина, Г. Н., Samoylova, А. G., Vasilyeva, I. A., & Burmistrova, I. A. (2023) · Tuberculosis and lung diseases · doi:10.21292/2075-1230-2022-100-12-28-32 · Cited by 1
A Review of the Association between Infections, Seizures, and Drugs
Tolou–Ghamari, Z. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249288932240416071636 · Cited by 2
Nisa, A. I., Damayanti, A. A., Nagasastra, J., Machin, A., Qorib, M. F., Retnaningsih, R., & Hamidi, B. L. (2024) · Folia Medica Indonesiana · doi:10.20473/fmi.v60i2.58931 · Cited by 1
Patil, S., Chen, X., & Wen, F. (2024) · Cellular Microbiology · doi:10.1155/2024/7938723 · Cited by 2
Mohammed, V., & Shanmugaraja, M. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05630-z · Cited by 1
Nithya, R., Neesha Solanky, K., Narmadha, U., Rajan, R. J., Ramya, A., & Manisha, B. (2023) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v13i7.6139 · Cited by 1
CHRONIC PAIN AND NEUROIMMUNE POSSIBLE PREDICTIVE FACTORS: REVIEW
Ksenchyna, K., Matolinets, N. V., Nazarchuk, O., Ivaniushko, O., & Dmytrіiev, D. (2024) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2024.01.08 · Cited by 1
Можокина, Г. Н., Samoylova, А. G., & Vasilyeva, I. A. (2024) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2024-102-3-6-11 · Cited by 1
Admin, Q. S. K., Vemulapalli, A. C., Elias, A. A., Yerramsetti, M. D., Olanisa, O. O., Jain, P., & Khan, S. (2023) · Journal For International Medical Graduates · doi:10.56570/jimgs.v2i2.135 · Cited by 3
Finsterer, J. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e368
Beta carotene provides neuroprotection against amikacin induced toxicity
Alhafidh, N. N., Faisal, I., & Saeed, M. G. (2023) · International Journal of Pharmacognosy and Life Science · doi:10.33545/27072827.2023.v4.i2a.94
The Effect of Nitrofurantoin on Tonic Seizures Induced by MES in Male Mice
Jalalian, A., Shafaroodi, H., & fereydani, M. (2024) · ACTA MEDICA IRANICA · doi:10.18502/acta.v61i10.15662
Toxicity and Allergies to Medications
Contreras‐Puentes, N., Castro-Leones, M., Gutiérrez-Tovar, B., & Galiz, J. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-93658-6_7 · Cited by 1
Amin, T., Shishir, M. A., Alam, M. M., Anam, M. B., Bulbul, N., Jime, J. S., & Fakruddin, M. (2025) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265362556250717063603
Awujo, C., Auwalu, L., Gaina, E., & Kolo, P. (2025) · International Journal of Clinical and Experimental Medical Sciences · doi:10.11648/j.ijcems.20251104.12
Photo-Responsive Antimicrobial Nanocoatings in the Nosocomial Setting
Soto-Garcia, L. F., Guerrero-Rodriguez, I. D., Dibert, L., & Nguyen, K. T. (2025) · Frontiers in Bioscience-Elite · doi:10.31083/fbe38083 · Cited by 2
Ksenchyna, K., Ksenchyn, O., Nazarchuk, O., & Дмитрієв, Д. В. (2026) · Frontiers in Pain Research · doi:10.3389/fpain.2026.1715446
“This coincided with the result obtained in our study (22).”
DR. ARMAGHAN-E-MARYAM JALAL, D. A. A. (2025) · TPM Testing, psychometrics, methodology in applied psychology · doi:10.5281/zenodo.19591744
Owumi, S. E., Olabisi, T. P., Chimezie, J., Eso, V. O., Owolabi, O. A., Sanusi, A. A., Babalola, J. O., Akomolafe, A. P., Arunsi, U. O., & Irozure, C. E. (2026) · Toxicon · doi:10.1016/j.toxicon.2026.109093
Ziółkowska, E., Nix, P., Olszowy, B., Williams, L. L., Eultgen, E. M., Nowacka, A., Celorrio, M., Friess, S. H., Heuckeroth, R. O., & Cooper, J. D. (2026) · Scientific Reports · doi:10.1038/s41598-026-49850-z
Corneal Sensitivity Changes and Nerve Plexus Abnormalities in Noninfectious Anterior Uveitis
Zhou, Y., Lin, L., 戴玛丽, Ran, G., Xin, Q., Li, J., Huang, Y., Wang, Y., & Chen, W. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.06.048
Ayala-Viqueira, J. (2026) · ScholarWorks (Walden University)
Antibiotics and the Endocrine System: Mechanisms, Adverse Effects, and Clinical Implications
Grabarczyk, Ł., Oszytko, J., Derkaczew, M., Sobolewski, K., & Radkowski, P. (2026) · Antibiotics · doi:10.3390/antibiotics15090857
“Frequently reported ADRs include allergic and hypersensitivity reactions, as well as neurological and gastrointestinal adverse effects [2].”
Advanced Computational Study of Herbal Extracts for Treating Pseudomonas aeruginosa Infections
Saini, M., Singh, K. K., Sharma, S., & Prakash, D. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-19521-0_17
Nugrahani, I., Wu, Y., Fatmawati, S., Uekusa, H., Wisesa, R., Uchida, M., & Wibowo, M. S. (2026) · Molecules · doi:10.3390/molecules31183189
Hachem, L., Darwish, B., Chaaban, M., Khadra, R., Shehade, H., Fayad, A. G. A., Bahmad, H. F., Daoud, G., & Abou-Kheir, W. G. (2026) · Advances in Urology · doi:10.1155/aiu/1858698
Нейропсихофармакологические аспекты действия антибиотиков
Андреевич, С. Ю., & Beyer, E. (2025) · Antibiot Khimioter = Antibiotics and Chemotherapy
Metadata
- Authors
- Hurkacz, M., Dobrek, L., & Wiela-Hojeńska, A.
- Affiliations
- Wroclaw Medical University (PL)
- Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-12-09
- Volume
- 26
- Issue
- 24
- Pages
- 7456
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8708917
- OpenAlex
- W4200466444
- Cited by
- 60
- References
- 135
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 13 · 2023: 18 · 2022: 7
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- antibiotics, drug-induced neurotoxicity, neuroprotection, beta-lactam antibiotics, quinolones, GABA transmission, benzodiazepine receptor, antibiotic resistance, gut dysbiosis, rifaximin, Alzheimer's disease, Parkinson's disease, neuroinflammation, adverse drug reactions
- MeSH terms
- Neuroprotection, Animals, Anti-Bacterial Agents, Humans, Nervous System, Neuroprotective Agents, Neurotoxicity Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.